THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS
暂无分享,去创建一个
P. Pickkers | E. Giamarellos‐Bourboulis | M. Kox | N. Antonakos | D. Markopoulou | Aline H. de Nooijer | I. Grondman | M. Netea
[1] L. Joosten,et al. Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID‐19 patients: A prospective observational study from the Netherlands , 2022, Clinical obesity.
[2] A. Koutsoukou,et al. Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial , 2022, Cell reports. Medicine.
[3] C. Lang,et al. Resistin production does not affect outcomes in a mouse model of acute surgical sepsis , 2022, PloS one.
[4] D. Khanna,et al. Obesity: A Chronic Low-Grade Inflammation and Its Markers , 2022, Cureus.
[5] H. Gelissen,et al. Effect of Low-Normal vs High-Normal Oxygenation Targets on Organ Dysfunction in Critically Ill Patients: A Randomized Clinical Trial. , 2021, JAMA.
[6] N. D. de Keizer,et al. Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients , 2021, Critical care medicine.
[7] Toshio Tanaka,et al. Adipocytokine Profile Reveals Resistin Forming a Prognostic-Related Cytokine Network in the Acute Phase of Sepsis , 2021, Shock.
[8] A. Malhotra,et al. Obesity and Critical Illness in COVID‐19: Respiratory Pathophysiology , 2021, Obesity.
[9] M. Jaeger,et al. A higher BMI is not associated with a different immune response and disease course in critically ill COVID-19 patients , 2021, International Journal of Obesity.
[10] M. Hedrick,et al. A flow cytometric assay for HLA‐DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials , 2021, Cytometry. Part B, Clinical cytometry.
[11] C. Lang,et al. Resistin directly inhibits bacterial killing in neutrophils , 2019, Intensive Care Medicine Experimental.
[12] P. Żelechowska,et al. Adipocytokine Involvement in Innate Immune Mechanisms. , 2018, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[13] M. Lazar,et al. Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction , 2017, Proceedings of the National Academy of Sciences.
[14] S. Orfanos,et al. Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis , 2017, BMC Medicine.
[15] M. Netea,et al. The immunopathology of sepsis and potential therapeutic targets , 2017, Nature Reviews Immunology.
[16] Liu Shuying,et al. “Obesity Paradox” in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-Analysis , 2016, PloS one.
[17] R. Bellomo,et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.
[18] E. Solomou,et al. The role of obesity in the immune response during sepsis , 2014, Nutrition & Diabetes.
[19] E. Abraham,et al. Human Resistin Promotes Neutrophil Proinflammatory Activation and Neutrophil Extracellular Trap Formation and Increases Severity of Acute Lung Injury , 2014, The Journal of Immunology.
[20] S. Jee,et al. Obesity survival paradox in pneumonia: a meta-analysis , 2014, BMC Medicine.
[21] Zi-hui Deng,et al. Diagnostic value of serum leptin and a promising novel diagnostic model for sepsis , 2014, Experimental and therapeutic medicine.
[22] R. Hotchkiss,et al. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy , 2013, Nature Reviews Immunology.
[23] Wei-Yen Hsu,et al. Resistin induces monocyte–endothelial cell adhesion by increasing ICAM‐1 and VCAM‐1 expression in endothelial cells via p38MAPK‐dependent pathway , 2011, Journal of cellular physiology.
[24] I. Hickman,et al. Changes in serum adiponectin concentrations in critical illness: a preliminary investigation , 2009, Critical care.
[25] Christian Trautwein,et al. Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients , 2009, Critical care.
[26] W. Hörl,et al. Resistin Inhibits Essential Functions of Polymorphonuclear Leukocytes , 2008, The Journal of Immunology.
[27] K. Walsh,et al. Adiponectin as an anti-inflammatory factor. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[28] C. Meisel,et al. Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study. , 2005, Clinical chemistry.
[29] U. Smith,et al. Resistin, an Adipokine with Potent Proinflammatory Properties1 , 2005, The Journal of Immunology.
[30] H. Tilg,et al. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. , 2003, Biochemical and biophysical research communications.
[31] M. Lazar,et al. The hormone resistin links obesity to diabetes , 2001, Nature.
[32] C. Dolea,et al. World Health Organization , 1949, International Organization.
[33] A. La Cava. Leptin in inflammation and autoimmunity , 2017, Cytokine.